Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04200534 · ClinicalTrials.gov registry record · Early Phase 1
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
A Early Phase 1 study of Lung Cancer and Smoking, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 358
- Enrollment target
- 3
- Study locations
NCT04200534: Active Early Phase 1 study of Lung Cancer and Smoking, sponsored by M.D. Anderson Cancer Center.
NCT04200534 is a Early Phase 1 study of Lung Cancer and Smoking that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 358 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04200534, a Early Phase 1 study of Lung Cancer and Smoking, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 358 participants
- Enrollment target
- 3
- Study locations
Study Summary
This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.
Primary Outcome
Participants achieving the primary abstinence endpoint at 12 weeks (higher 7-day point prevalence abstinence rates)
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Tobacco Cessation Counseling
- DRUG Nicotine Patch
Study Locations (3)
Texas
- University of Texas Medical Branch - Galveston
- M D Anderson Cancer Center - Houston
- University of Texas Health Science Center at Tyler - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2020-07-31 |
| Est. Completion | 2027-02-28 |
| Phase | Early Phase 1 |
What the registry record for NCT04200534 still lists
NCT04200534 is an interventional study that assigns participants to a tested intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04200534 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04200534 about?
NCT04200534 is a clinical study titled "Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)". This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are ref...
What is the current status of trial NCT04200534?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 358 participants. The study started on 2020-07-31. Estimated completion is 2027-02-28.
What conditions does trial NCT04200534 study?
This clinical trial studies the following conditions: Lung Cancer, Smoking.
What interventions are being tested in trial NCT04200534?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Tobacco Cessation Counseling (OTHER), Nicotine Patch (DRUG).
Who is sponsoring clinical trial NCT04200534?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04200534 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04200534's enrollment target sits among peer trials
358 89th of 409 higher than 321 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
RECRUITING · Early Phase 1
-
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
RECRUITING · Early Phase 1
-
Microdevice for Evaluating Drug Response in Site in Lung Lesions
COMPLETED · Early Phase 1
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373317 · 358 participants · Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- NCT05684965 · 358 participants · Phase 1
XTX301 in Patients With Advanced Solid Tumors
- NCT05824975 · 358 participants · Phase 1
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- NCT06480227 · 358 participants · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI